Scientech Research’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
Other funds holding APRE
ACM
Scientech Research's APRE Position: Q2 2026 in Review
Scientech Research sold out of Aprea Therapeutics (APRE) in Q2 2026, closing a stake of 60,281 shares — an estimated $46K sold.
Scientech Research first reported a position in APRE in Q1 2026 and held it in 1 quarter. The position peaked at $46K in Q1 2026. 27 funds tracked by Wall St. Rank hold APRE as of Q2 2026.
- Scientech Research reported no remaining Aprea Therapeutics position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 60,281 Aprea Therapeutics shares in Q2 2026, an estimated $46K.
- Scientech Research first reported a position in Aprea Therapeutics in Q1 2026 and held it in 1 quarter.
- Scientech Research's Aprea Therapeutics position peaked at $46K in Q1 2026.
- 27 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.